Corcept Therapeutics

Krystal Biotech

Avidity Biosciences

Arcellx

Alkermes

Crinetics Pharmaceuticals Inc

Immunovant Inc

Denali Therapeutics

Agios Pharmaceuticals

Merus

ALPS Medical Breakthroughs ETF

SBIO tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials.

Virtus LifeSci Biotech Clinical Trials ETF

Loncar Cancer Immunotherapy ETF

ROBO Global Healthcare Technology and Innovation ETF

iShares Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

Invesco Dynamic Biotechnology & Genome ETF

SPDR S&P Biotech ETF

Can biotech ETFs repeat its success story of 2019 in the election year of 2020?

Will Biotech ETFs Excel in Election Year Post a Surge in 2019?

Global X Genomics & Biotechnology ETF

Following the new deals in the healthcare space, a few biotech ETFs hit new highs.

Biotech ETFs Hit New Highs on Deal Activities

ARK Genomic Revolution Multi-Sector ETF

VanEck Vectors Biotech ETF

Virtus LifeSci Biotech Products ETF

Principal Healthcare Innovators Index ETF

First Trust NYSE Arca Biotechnology Index Fund

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.

A Guide to Biotech ETF Investing

ALPS Clean Energy ETF

VanEck Junior Gold Miners ETF

Amplify Junior Silver Miners ETF

Vanguard Small-Cap Growth

Small caps started to show their momentum and are trying to catch up with the large cap peers. The Russell 2000 Index hit a new 52-week high.

Russell 2000 Hits New 1-Year High: 5 Best-Performing ETFs

iShares U.S. Home Construction ETF

VanEck Vectors Semiconductor ETF

Invesco Solar ETF

SPDR S&P Aerospace & Defense ETF

These ETFs deserve special thanks and attention going into the New Year.

5 ETFs That Deserve Special Thanks in 2019

iShares U.S. Healthcare Providers ETF

Ironwood Pharma

Jounce Therapeutics

Osmotica Pharmaceuticals Plc

Select Medical Holdings

Healthcare bounced back with an outperformance starting the fourth quarter.

Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD

VanEck Vectors Oil Refiners ETF

First Trust Nasdaq Semiconductor ETF

US Global Sea to Sky Cargo ETF

iShares Global Timber & Forestry ETF

October has been kind to the U.S. stock market thanks to U.S.

5 Best Sector ETFs of October With Double-Digit Returns

SPDR S&P Pharmaceuticals ETF

The healthcare sector, which has been the second-worst performer among the 11 major S&P 500 sectors this year, took the center stage this month with some outperformance compared to other sectors.

Healthcare ETFs Win in October: Here's Why

Hepion Pharmaceuticals Inc

The biotech sector got a boost over the past week from a flurry of positive news including trial results and deal activities.

Biotech ETFs Surge on a Flurry of Positive News

While the rest of the biotechnology sector remained depressed along with the broader markets, related exchange traded funds found strength from an unexpected surge in ACADIA Pharmaceuticals (NasdaqGS: ACAD), following the biopharma company’s positive announcement for a phase 3 trail on dementia-related psychosis.

ACADIA Pharmaceuticals Help Lift Biotech ETFs

Invesco S&P SmallCap Health Care ETF

The healthcare sector has been the worst performing on the S&P 500 in 2019, but these biotech ETFs are still worth a look.

Biotech ETFs That Should Remain Healthy

Pfizer struck a deal to acquire the cancer drugmaker Array Biopharma for $11 billion in an all-cash consideration.

Pfizer-Array Biopharma Deal Bump Up Biotech ETFs

Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

Biotechnology Market on a Tear: 5 ETFs in Spotlight

News for ALPS Medical Breakthroughs ETF ETF (SBIO)